0001654706-17-000003.txt : 20170801
0001654706-17-000003.hdr.sgml : 20170801
20170801141441
ACCESSION NUMBER: 0001654706-17-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06c
FILED AS OF DATE: 20170801
DATE AS OF CHANGE: 20170801
EFFECTIVENESS DATE: 20170801
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Indalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001654706
IRS NUMBER: 473395909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-291882
FILM NUMBER: 17996168
BUSINESS ADDRESS:
STREET 1: 4320 FOREST PARK AVENUE
STREET 2: SUITE 304
CITY: ST. LOUIS
STATE: MO
ZIP: 63108
BUSINESS PHONE: 314-882-6886
MAIL ADDRESS:
STREET 1: 4320 FOREST PARK AVENUE
STREET 2: SUITE 304
CITY: ST. LOUIS
STATE: MO
ZIP: 63108
FORMER COMPANY:
FORMER CONFORMED NAME: Antegrin Therapeutics, Inc.
DATE OF NAME CHANGE: 20151002
D
1
primary_doc.xml
X0708
D
LIVE
0001654706
Indalo Therapeutics, Inc.
4320 FOREST PARK AVENUE
SUITE 304
ST. LOUIS
MO
MISSOURI
63108
314-932-4032
DELAWARE
Antegrin Therapeutics, Inc.
Corporation
true
2014
George
H.
Capps II
c/o Indalo Therapeutics, Inc.
4320 Forest Park Avenue, Suite 304
St. Louis
MO
MISSOURI
63108
Executive Officer
Promoter
Ben
Auspitz
c/o Indalo Therapeutics, Inc.
4320 Forest Park Avenue, Suite 304
St. Louis
MO
MISSOURI
63108
Director
Peter
Barrett
c/o Indalo Therapeutics, Inc.
4320 Forest Park Avenue, Suite 304
St. Louis
MO
MISSOURI
63108
Director
Scott
Seiwert
c/o Indalo Therapeutics, Inc.
4320 Forest Park Avenue, Suite 304
St. Louis
MO
MISSOURI
63108
Executive Officer
Bradford
Williamson
c/o Indalo Therapeutics, Inc.
4320 Forest Park Avenue, Suite 304
St. Louis
MO
MISSOURI
63108
Executive Officer
Rajesh
Devraj
c/o Indalo Therapeutics, Inc.
4320 Forest Park Avenue, Suite 304
St. Louis
MO
MISSOURI
63108
Director
Pharmaceuticals
Decline to Disclose
- 06c
false
2017-06-30
false
true
false
0
25999992
8999996
16999996
false
6
0
0
0
false
Indalo Therapeutics, Inc.
/s/ George H. Capps II
George H. Capps II
Chief Executive Officer
2017-08-01